scholarly article | Q13442814 |
P50 | author | Gautam N Bijur | Q124296519 |
P2093 | author name string | Taj D King | |
Buffie Clodfelder-Miller | |||
Keri A Barksdale | |||
P2860 | cites work | Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3β and attenuated by lithium | Q43786473 |
Central role of glycogen synthase kinase-3beta in endoplasmic reticulum stress-induced caspase-3 activation | Q44135113 | ||
Vitamin E blocks early events induced by 1-methyl-4-phenylpyridinium (MPP+) in cerebellar granule cells. | Q44297193 | ||
Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin | Q45297269 | ||
Role of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway | Q47762057 | ||
Inhibition of glycogen synthase kinase-3beta protects dopaminergic neurons from MPTP toxicity | Q48160464 | ||
Hypertonic Stress Activates Glycogen Synthase Kinase 3β-mediated Apoptosis of Renal Medullary Interstitial Cells, Suppressing an NFκB-driven Cyclooxygenase-2-dependent Survival Pathway | Q64377327 | ||
Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement | Q67724128 | ||
1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles | Q68474033 | ||
Abnormalities of the electron transport chain in idiopathic Parkinson's disease | Q69361952 | ||
Glycogen synthase from rabbit skeletal muscle. State of phosphorylation of the seven phosphoserine residues in vivo in the presence and absence of adrenaline | Q72756052 | ||
Purification of Glycogen Synthase Kinase 3 from Rabbit Skeletal Muscle.. Copurification with the Activating Factor (FA)of the (Mg-ATP) Dependent Protein Phosphatase | Q72914857 | ||
Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal | Q73575616 | ||
Glycogen synthase kinase 3beta negatively regulates both DNA-binding and transcriptional activities of heat shock factor 1 | Q73901311 | ||
Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage | Q24534352 | ||
A molecular mechanism for the effect of lithium on development | Q24629067 | ||
GSK3beta and endoplasmic reticulum stress mediate rotenone-induced death of SK-N-MC neuroblastoma cells | Q28116897 | ||
The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation | Q28264432 | ||
Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization | Q28290083 | ||
Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase | Q28302692 | ||
Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 beta | Q28345704 | ||
Different localization of tau protein kinase I/glycogen synthase kinase-3 beta from glycogen synthase kinase-3 alpha in cerebellum mitochondria | Q28574200 | ||
Chronic systemic pesticide exposure reproduces features of Parkinson's disease | Q29614763 | ||
The glamour and gloom of glycogen synthase kinase-3 | Q29620533 | ||
Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines | Q30305471 | ||
Complex I deficiency in Parkinson's disease frontal cortex | Q30440448 | ||
Origin and functional consequences of the complex I defect in Parkinson's disease | Q30469425 | ||
Scaffold hopping and optimization towards libraries of glycogen synthase kinase-3 inhibitors | Q30732148 | ||
Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation | Q31034955 | ||
An endogenous serine/threonine protein phosphatase inhibitor, G-substrate, reduces vulnerability in models of Parkinson's disease | Q33292773 | ||
Glycogen synthase kinase-3 beta is highly activated in nuclei and mitochondria | Q34282190 | ||
Mitochondrial fission in apoptosis, neurodegeneration and aging | Q35595919 | ||
Generation of superoxide by the mitochondrial Complex I. | Q36469867 | ||
Mitochondrial reactive oxygen species and Ca2+ signaling | Q36499631 | ||
Human NADH:ubiquinone oxidoreductase deficiency: radical changes in mitochondrial morphology? | Q36788822 | ||
Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity | Q37683630 | ||
Overexpressed alpha-synuclein regulated the nuclear factor-kappaB signal pathway | Q40090895 | ||
Glycogen synthase kinase 3beta modulates synphilin-1 ubiquitylation and cellular inclusion formation by SIAH: implications for proteasomal function and Lewy body formation. | Q40370849 | ||
Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death | Q40558100 | ||
Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant | Q40990869 | ||
Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease | Q41015571 | ||
Rapid changes of mitochondrial Ca2+ revealed by specifically targeted recombinant aequorin | Q41112236 | ||
Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium | Q42484847 | ||
P433 | issue | 4 | |
P921 | main subject | mitochondrion | Q39572 |
P304 | page(s) | 367-382 | |
P577 | publication date | 2008-12-01 | |
P1433 | published in | Neurotoxicity Research | Q15764278 |
P1476 | title | Unregulated mitochondrial GSK3beta activity results in NADH: ubiquinone oxidoreductase deficiency | |
P478 | volume | 14 |
Q90627832 | A mitochondrial journey through acetaminophen hepatotoxicity |
Q35414051 | Accelerated recovery of mitochondrial membrane potential by GSK-3β inactivation affords cardiomyocytes protection from oxidant-induced necrosis |
Q38200488 | Association of glycogen synthase kinase-3β with Parkinson's disease (review). |
Q50079172 | Cilostazol Mediated Nurr1 and Autophagy Enhancement: Neuroprotective Activity in Rat Rotenone PD Model |
Q91867181 | Dysfunctional Mitochondria and Mitophagy as Drivers of Alzheimer's Disease Pathogenesis |
Q38079592 | GSK-3 and mitochondria in cancer cells. |
Q36378223 | GSK3β inhibition protects the immature brain from hypoxic-ischaemic insult via reduced STAT3 signalling |
Q38862322 | Impact of intracellular ion channels on cancer development and progression |
Q28472669 | Light and electron microscopy study of glycogen synthase kinase-3beta in the mouse brain |
Q28247202 | Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects |
Q98289622 | Mechanisms of the Regulation and Dysregulation of Glucagon Secretion |
Q97644577 | Modulated Expression of the Protein Kinase GSK3 in Motor and Dopaminergic Neurons Increases Female Lifespan in Drosophila melanogaster |
Q60932964 | Pathogenic Feed-Forward Mechanisms in Alzheimer's and Parkinson's Disease Converge on GSK-3 |
Q26800952 | Resveratrol: A Focus on Several Neurodegenerative Diseases |
Q26749074 | The Dual Function of Reactive Oxygen/Nitrogen Species in Bioenergetics and Cell Death: The Role of ATP Synthase |
Q36146320 | The Mitochondrial Permeability Transition Pore: Channel Formation by F-ATP Synthase, Integration in Signal Transduction, and Role in Pathophysiology. |
Q38278265 | The mitochondrial permeability transition pore and its adaptive responses in tumor cells |
Q30593479 | Translocation of glycogen synthase kinase-3β (GSK-3β), a trigger of permeability transition, is kinase activity-dependent and mediated by interaction with voltage-dependent anion channel 2 (VDAC2). |
Q47301971 | Understanding the role of glycogen synthase kinase-3 in L-DOPA-induced dyskinesia in Parkinson's disease |
Search more.